P

Procept Biorobotics Corp
NASDAQ:PRCT

Watchlist Manager
Procept Biorobotics Corp
NASDAQ:PRCT
Watchlist
Price: 58 USD 4.11% Market Closed
Market Cap: 3.2B USD

Wall Street
Price Targets

PRCT Price Targets Summary
Procept Biorobotics Corp

Wall Street analysts forecast PRCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRCT is 79.9 USD with a low forecast of 60.6 USD and a high forecast of 94.5 USD.

Lowest
Price Target
60.6 USD
4% Upside
Average
Price Target
79.9 USD
38% Upside
Highest
Price Target
94.5 USD
63% Upside
Procept Biorobotics Corp Competitors:
Price Targets
338220
Vuno Inc
113% Upside
COH
Cochlear Ltd
9% Upside
PRM
Prim SA
58% Upside
BDX
Becton Dickinson and Co
30% Upside
688271
Shanghai United Imaging Healthcare Co Ltd
18% Upside
IDXX
IDEXX Laboratories Inc
1% Upside
2252
Shanghai MicroPort MedBot Group Co Ltd
59% Upside
AFX
Carl Zeiss Meditec AG
12% Upside

Revenue
Forecast

Revenue Estimate
Procept Biorobotics Corp

For the last 4 years the compound annual growth rate for Procept Biorobotics Corp's revenue is 132%. The projected CAGR for the next 3 years is 35%.

132%
Past Growth
35%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Procept Biorobotics Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Procept Biorobotics Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRCT's stock price target?
Price Target
79.9 USD

According to Wall Street analysts, the average 1-year price target for PRCT is 79.9 USD with a low forecast of 60.6 USD and a high forecast of 94.5 USD.

What is Procept Biorobotics Corp's Revenue forecast?
Projected CAGR
35%

For the last 4 years the compound annual growth rate for Procept Biorobotics Corp's revenue is 132%. The projected CAGR for the next 3 years is 35%.

Back to Top